Progressive muscle relaxation to reduce anxiety before electroconvulsive therapy (ECT)

渐进式肌肉放松法可减轻电休克疗法(ECT)前的焦虑

阅读:1

Abstract

BACKGROUND: ECT is a well-established treatment modality for severe psychiatric disorders, particularly major depressive disorder and bipolar disorder. It is well-documented that patients experience significant anxiety before treatment, which can adversely affect nursing care and the treatment process. This study aims to determine the effect of progressive muscle relaxation exercises on anxiety levels among patients with bipolar and depressive disorders prior to their first ECT session. METHOD: Data for this quasi-experimental study were collected from 30 in-patients with bipolar disorder and depression who received ECT for the first time in the hospital between May 29 and October 29, 2020. Data collection involved an information form, the STAXI State Anxiety Scale, and the Visual Analogue Scale for Anxiety. The data were analyzed using descriptive statistics, the Friedman test, and the Wilcoxon test. RESULTS: The mean VAS-A score decreased from 4.93 ± 1.88 before PMR to 2.83 ± 1.76 after PMR, and further to 1.43 ± 1.21 after ECT (p < .001). However, STAI-S scores did not show a statistically significant difference before and after PMR (p > .05). Heart rate and respiratory rate also significantly decreased after PMR exercises (p < .05), while oxygen saturation remained unchanged. Prior to the next ECT session, the mean VAS-A score increased to 5.10 ± 1.77, and no significant changes were observed in either physiological parameters or anxiety measures. CONCLUSION: While a short-term effect on VAS Anxiety levels was observed following PMR exercises before ECT, patients still exhibited high levels of anxiety before subsequent ECT sessions. Therefore, it is recommended that PMR exercises be performed before each ECT session, and the effects of long-term application should be further investigated. Future studies should employ a randomized controlled design to compare results with a control group. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。